Peer-reviewed veterinary case report
Cat with constipation diagnosed with retroperitoneal eosinophilic
By Maureen E Thieme et al.·Published in JFMS open reports·2019·View original on Semantic Scholar →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Diagnosis and management of a case of retroperitoneal eosinophilic sclerosing fibroplasia in a cat
- Species:
- cat
Plain-English summary
A 4-year-old neutered male cat was brought in for constipation that got worse over two months, leading to severe difficulty passing stool. The vet found a large mass in the cat's abdomen that was pressing on the colon. After surgery to remove the mass, the cat was treated with medications including prednisolone, antibiotics, and a dewormer. Six months later, the cat showed no signs of the original problem, and follow-up imaging confirmed significant improvement.
People also search for: cat constipation treatment · cat abdominal mass · feline eosinophilic sclerosing fibroplasia · cat surgery recovery · prednisolone for cats
Abstract
Case summary A 4-year-old neutered male cat was presented with a 2-month history of intermittent constipation that progressed to obstipation. Primary clinical findings included a large, multi lobulated mass in the caudodorsal abdomen, peripheral eosinophilia and hyperglobulinemia. Abdominal imaging revealed a multilobulated, cavitated mass in the sublumbar region. Exploratory celiotomy revealed multiple firm masses in the sublumbar retroperitoneal space causing ventral displacement and compression of the descending colon with extension of the masses into the pelvic canal. Histopathology was consistent with feline gastrointestinal eosinophilic sclerosing fibroplasia (FGESF). Aerobic culture was positive for Staphylococcus aureus. The cat was treated with prednisolone (2 mg/kg PO q24h), lactulose (0.5 g/kg PO q8h), amoxicillin/clavulanic acid (62.5 mg/cat PO q12h for 1 month) and fenbendazole (50 mg/kg PO q24h for 5 days). Six months postoperatively, the cat had no recurrence of clinical signs. Repeat evaluation and imaging at day 732 postoperatively revealed marked improvement of the abdominal mass, resolution of peripheral eosinophilia and no clinical signs with continued prednisolone therapy (0.5 mg/kg PO q24h). Relevance and novel information This is a report of a primary extramural FGESF lesion, and the first description of characteristics of FGESF on CT. Previous evidence suggests that the most favorable outcomes require immunosuppressive therapy and complete surgical excision; however, this case demonstrates a favorable outcome with medical management alone.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Semantic Scholar: https://www.semanticscholar.org/paper/31452913